Lexicon Pharmaceuticals
LXRX
#6861
Rank
NZ$1.24 B
Marketcap
NZ$2.79
Share price
-8.38%
Change (1 day)
7.64%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): NZ-$0.25

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$0.26. In 2025 the company made an earnings per share (EPS) of NZ-$0.26 an increase over its 2024 EPS that were of NZ-$1.17.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.25-3.82%
2025NZ-$0.26-78.13%
2024NZ-$1.17-20%
2023NZ-$1.4631.15%
2022NZ-$1.11-0%
2021NZ-$1.1110.91%
2020NZ-$1.00-145.08%
2019NZ$2.23-206.09%
2018NZ-$2.10-5.74%
2017NZ-$2.23-10.95%
2016NZ-$2.502640%
2015NZ-$0.09122-96.34%
2014NZ-$2.49-2.53%
2013NZ-$2.55-9.09%
2012NZ-$2.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$34.64-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$10.75-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$85.71-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ-$9.47 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.73-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03649-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ-$1.37 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ-$53.43 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA